Anyone who has been diagnosed with cancer or who has known someone who has been diagnosed is aware of the mental, physical and emotional toll the disease will take through diagnosis and treatment. Ovarian cancer is no exception, and with more than 22,000 women in the U.S. projected to be diagnosed with ovarian cancer annually, there needs to be a better understanding of the disease. Ovarian cancer is the 5th leading cause of cancer death in American women.
To identify the unmet education and support needs of the advanced ovarian cancer community, TESARO, in tandem with National Ovarian Cancer Coalition (NOCC) and Ovarian Cancer Research Fund Alliance (OCRFA), developed and fielded the Our Way Forward survey to patients and oncologists. This national survey found regardless of the stage of ovarian cancer, there is uncertainty among patients about what to expect after diagnosis – whether they are initially diagnosed or actively seeking greater resources and connections with others to lessen the burden of the disease.
Leveraging insights gleaned from the survey, Our Way Forward provides informed resources aimed at bringing the community together by sharing stories and perspectives to help women navigate their ovarian cancer experiences.